FDA NDC Directory · JSON-LD · Markdown

Varubi

NDC 87628-101 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namerolapitant
Labeler / ManufacturerLuria Therapeutics LLC
Marketing categoryNew Drug Application (innovator) · App NDA206500
Dosage form / routeTABLET · ORAL
Active ingredientsROLAPITANT HYDROCHLORIDE (90 mg/1)
Marketing started20260820
Package count1

External sources

Source: openFDA. Public-domain (CC0).